US Stock MarketDetailed Quotes

RAPP Rapport Therapeutics

Watchlist
  • 22.480
  • +0.140+0.63%
Trading Nov 27 11:50 ET
822.24MMarket Cap-11446P/E (TTM)

Rapport Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
--320.66M
--336.14M
--193.24M
373.31%147.48M
--147.48M
--31.16M
-Cash and cash equivalents
--39.31M
--110.16M
--74.27M
125.20%70.17M
--70.17M
--31.16M
-Short-term investments
--281.35M
--225.98M
--118.98M
--77.31M
--77.31M
--0
Restricted cash
--105K
--105K
--105K
--85K
--85K
--0
Other current assets
--5.17M
--4.42M
--5.38M
2,935.78%3.31M
--3.31M
--109K
Total current assets
--325.94M
--340.67M
--198.73M
382.51%150.87M
--150.87M
--31.27M
Non current assets
Net PPE
--5.02M
--5.24M
--5.49M
1,094.03%4M
--4M
--335K
-Gross PPE
--5.72M
--5.73M
--5.77M
1,079.14%4.13M
--4.13M
--350K
-Accumulated depreciation
---705K
---485K
---279K
-746.67%-127K
---127K
---15K
Other non current assets
--189K
--189K
--2.07M
--551K
--551K
----
Total non current assets
--5.21M
--5.43M
--7.56M
1,258.51%4.55M
--4.55M
--335K
Total assets
--331.14M
--346.1M
--206.29M
391.80%155.42M
--155.42M
--31.6M
Liabilities
Current liabilities
Payables
--1.32M
--1.88M
--1.45M
72.55%2.5M
--2.5M
--1.45M
-accounts payable
--1.32M
--1.88M
--1.45M
72.55%2.5M
--2.5M
--1.45M
Current accrued expenses
--1.83M
--3.81M
--6.71M
1,410.80%3.22M
--3.22M
--213K
Current debt and capital lease obligation
--720K
--703K
--686K
--670K
--670K
----
-Current capital lease obligation
--720K
--703K
--686K
--670K
--670K
--0
Current liabilities
--7.1M
--8.1M
--9.89M
429.34%8.8M
--8.8M
--1.66M
Non current liabilities
Long term debt and capital lease obligation
--931K
--1.12M
--1.3M
--1.48M
--1.48M
--0
-Long term capital lease obligation
--931K
--1.12M
--1.3M
--1.48M
--1.48M
--0
Preferred securities outside stock equity
--0
--0
--234.74M
326.92%170.78M
--170.78M
--40M
Total non current liabilities
--931K
--1.12M
--236.04M
330.61%172.25M
--172.25M
--40M
Total liabilities
--8.03M
--9.21M
--245.92M
334.55%181.06M
--181.06M
--41.67M
Shareholders'equity
Share capital
--36K
--36K
--4K
0.00%4K
--4K
--4K
-common stock
--36K
--36K
--4K
0.00%4K
--4K
--4K
-Preferred stock
--0
----
----
----
----
----
Retained earnings
---103.77M
---86.23M
---68.11M
-326.57%-45.44M
---45.44M
---10.65M
Paid-in capital
--426.44M
--423.26M
--28.63M
3,278.16%19.8M
--19.8M
--586K
Gains losses not affecting retained earnings
--400K
---183K
---160K
--4K
--4K
--0
Total stockholders'equity
--323.11M
--336.89M
---39.63M
-154.76%-25.63M
---25.63M
---10.06M
Total equity
--323.11M
--336.89M
---39.63M
-154.76%-25.63M
---25.63M
---10.06M
Currency Unit
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments --320.66M--336.14M--193.24M373.31%147.48M--147.48M--31.16M
-Cash and cash equivalents --39.31M--110.16M--74.27M125.20%70.17M--70.17M--31.16M
-Short-term investments --281.35M--225.98M--118.98M--77.31M--77.31M--0
Restricted cash --105K--105K--105K--85K--85K--0
Other current assets --5.17M--4.42M--5.38M2,935.78%3.31M--3.31M--109K
Total current assets --325.94M--340.67M--198.73M382.51%150.87M--150.87M--31.27M
Non current assets
Net PPE --5.02M--5.24M--5.49M1,094.03%4M--4M--335K
-Gross PPE --5.72M--5.73M--5.77M1,079.14%4.13M--4.13M--350K
-Accumulated depreciation ---705K---485K---279K-746.67%-127K---127K---15K
Other non current assets --189K--189K--2.07M--551K--551K----
Total non current assets --5.21M--5.43M--7.56M1,258.51%4.55M--4.55M--335K
Total assets --331.14M--346.1M--206.29M391.80%155.42M--155.42M--31.6M
Liabilities
Current liabilities
Payables --1.32M--1.88M--1.45M72.55%2.5M--2.5M--1.45M
-accounts payable --1.32M--1.88M--1.45M72.55%2.5M--2.5M--1.45M
Current accrued expenses --1.83M--3.81M--6.71M1,410.80%3.22M--3.22M--213K
Current debt and capital lease obligation --720K--703K--686K--670K--670K----
-Current capital lease obligation --720K--703K--686K--670K--670K--0
Current liabilities --7.1M--8.1M--9.89M429.34%8.8M--8.8M--1.66M
Non current liabilities
Long term debt and capital lease obligation --931K--1.12M--1.3M--1.48M--1.48M--0
-Long term capital lease obligation --931K--1.12M--1.3M--1.48M--1.48M--0
Preferred securities outside stock equity --0--0--234.74M326.92%170.78M--170.78M--40M
Total non current liabilities --931K--1.12M--236.04M330.61%172.25M--172.25M--40M
Total liabilities --8.03M--9.21M--245.92M334.55%181.06M--181.06M--41.67M
Shareholders'equity
Share capital --36K--36K--4K0.00%4K--4K--4K
-common stock --36K--36K--4K0.00%4K--4K--4K
-Preferred stock --0--------------------
Retained earnings ---103.77M---86.23M---68.11M-326.57%-45.44M---45.44M---10.65M
Paid-in capital --426.44M--423.26M--28.63M3,278.16%19.8M--19.8M--586K
Gains losses not affecting retained earnings --400K---183K---160K--4K--4K--0
Total stockholders'equity --323.11M--336.89M---39.63M-154.76%-25.63M---25.63M---10.06M
Total equity --323.11M--336.89M---39.63M-154.76%-25.63M---25.63M---10.06M
Currency Unit USDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data